recombinant α synuclein e46k (MedChemExpress)
93
Structured Review
MedChemExpress
recombinant α synuclein e46k
Recombinant α Synuclein E46k, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p3140a/%CE%B1-Synuclein/10__1016_slash_j__dyepig__2025__113160-150-2-11
Average 93 stars, based on 1 article reviews
Recombinant α Synuclein E46k, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p3140a/%CE%B1-Synuclein/10__1016_slash_j__dyepig__2025__113160-150-2-11
Average 93 stars, based on 1 article reviews
recombinant α synuclein e46k - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Activity Assay:Article Title: Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence Article Snippet: After 6 days of culture, the dopaminergic neurons were injured with α-syn (250 nmol/L) up to 168 h. Dynasore (Selleckchem, Houston, TX, USA), an inhibitor of clathrin-mediated endocytosis was applied for 2 h, 6 h or 96 h, from day 6 of culture, in presence of α-syn (250 nmol/L). .. Conduritol B epoxide (MedChem Express, Sollentuna, Sweden), an inhibitor of GBA, was applied alone (at 20 µmol/L, inducing around 50% decrease of GBA activity) or combined with Article Title: Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence. Article Snippet: After 6 days of culture, the dopaminergic neurons were injured with α-syn (250 nmol/L) up to 168 h. Dynasore (Selleckchem, Houston, TX, USA), an inhibitor of clathrin-mediated endocytosis was applied for 2 h, 6 h or 96 h, from day 6 of culture, in presence of α-syn (250 nmol/L). .. Conduritol B epoxide (MedChem Express, Sollentuna, Sweden), an inhibitor of GBA, was applied alone (at 20 μmol/L, inducing around 50% decrease of GBA activity) or combined with Inhibition:Article Title: α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome Article Snippet: .. The drug treatment group was treated with 10 μg/ml oligomerized Article Title: α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome. Article Snippet: .. The drug treatment group was treated with 10 μg/ml oligomerized Western Blot:Article Title: α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome. Article Snippet: .. The drug treatment group was treated with 10 μg/ml oligomerized Recombinant:Article Title: Highly selective small molecular fluorescence probes for detecting α-syn fibrils Article Snippet: Misfolded α-synuclein (α-Syn) is a major pathological hallmark of Parkinson’s disease (PD), and small-molecule fluorescent probes targeting α-Syn could significantly advance etiology studies, enable early diagnosis, and support therapeutic evaluation.. However, the advancement of selective probes has been hindered by the structural resemblance between α-Syn and β-amyloid (Aβ) fibrils.. Herein, we presented a series of donoracceptor-based fluorescent probes that exhibit remarkable selectivity for α-Syn over Aβ. Concentration Assay:Article Title: Highly selective small molecular fluorescence probes for detecting α-syn fibrils Article Snippet: Misfolded α-synuclein (α-Syn) is a major pathological hallmark of Parkinson’s disease (PD), and small-molecule fluorescent probes targeting α-Syn could significantly advance etiology studies, enable early diagnosis, and support therapeutic evaluation.. However, the advancement of selective probes has been hindered by the structural resemblance between α-Syn and β-amyloid (Aβ) fibrils.. Herein, we presented a series of donoracceptor-based fluorescent probes that exhibit remarkable selectivity for α-Syn over Aβ. |